SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Welcome to the GENT board. GENT has the first drug for VOD.
An SI Board Since July 2006
Posts SubjectMarks Bans Symbol
408 17 0 GENT
Emcee:  rareearth42 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
183[Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multituck-1/9/2010
182Gentium Announces Final Clinical Trial Results for Defibrotide Presented at the tnsaf-12/7/2009
181Big contrast to early data. Any idea why the miss? Gentium Reports Top Line ReIRWIN JAMES FRANKEL18/19/2009
180Market seems to like it.tom pope-8/6/2009
179Gentium Announces Director Resignations and Other Governance Changes * PresIRWIN JAMES FRANKEL-8/6/2009
178Missed your post to me somehow. I don't know how to play this stock at thiskenhott-4/3/2009
177The wisdom of my position that I'll wait until financing to re-enter is conftuck-3/31/2009
176>>Gentium Announces Preliminary Results from a Phase 2/3 European Pediatrituck-3/30/2009
175[Defibrotide therapy for patients with sinusoidal obstruction syndrome after hemtuck-2/22/2009
174Gentium Announces Completion of Enrollment for the Phase II/III European Pediatrkenhott-1/22/2009
173Pediatric trial enrolling well, but company will run out of cash before results tuck-12/17/2008
17232/86, that is like 40%. Good average for baseball. >While we were hoping tkenhott-11/20/2008
171I think it is unethical but unfortunately it might be the only way to get the drrkrw-11/19/2008
170>>do a placebo controlled study. Thought that unethical since could be fIRWIN JAMES FRANKEL111/19/2008
169Only 32/86 on historical control qualified. Best hope seems to be find anotherrkrw-11/19/2008
168You stop pumping this stock. :) Up another good %s. Now what do I do????? lokenhott-11/18/2008
167Defibrotide as adjuvant in small cell lung cancer] Przegl Lek. 2008;65(7-8):321tuck-11/17/2008
166<Sure would like to know what the hell is happening...> They are in Italykenhott-11/17/2008
165Can you believe these jerks haven't made a public announcement about whatfred hayes-11/14/2008
164[Angiogenesis alteration by defibrotide: implications for its mechanism of actiotuck-11/9/2008
163>>Anyone with any guesses of why Sigma Tau would try to block Gentium fromIRWIN JAMES FRANKEL-11/7/2008
162<reply> Ohhhhh that is going to be interesting. Maybe he will pretend to kenhott-11/7/2008
161The only thing for sure is that mgt is playing some kind of game. (1) Sigma eitkenhott-11/7/2008
160Anyone with any guesses of why Sigma Tau would try to block Gentium from doing arkrw-11/5/2008
159Tuck, I wouldn't want to venture on who might be liquidating but gent is a brkrw-11/4/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News